The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Expansion Is Predicted For The Personalized Medicine Market Between 2026 And 2030?
The personalized medicine market has experienced rapid expansion over recent years. This market is projected to grow from $422.9 billion in 2025 to $469.11 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.9%. The historical growth can be attributed to an increasing prevalence of chronic diseases, advancements in genetic sequencing, higher healthcare expenditure, growing awareness of personalized medicine, and the early adoption of digital health solutions.
The personalized medicine market is projected to experience significant expansion over the next few years, with its size reaching $733.27 billion by 2030, propelled by a compound annual growth rate (CAGR) of 11.8%. This growth throughout the forecast period stems from the integration of AI in diagnostics and therapeutics, the broadening scope of gene and cell therapy products, increasing demand for remote patient monitoring, the evolution of precision nutrition solutions, and the rising adoption of companion diagnostics. Prominent trends anticipated within this period involve personalized genetic profiling, the development of targeted drugs, patient-centric care frameworks, remote health monitoring, and lifestyle-based preventive therapies.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10272&type=smp
Which Growth Drivers Are Contributing To The Progress Of The Personalized Medicine Market?
The increasing number of individuals affected by obesity is anticipated to boost the expansion of the personalized medicine market in the future. Obesity is characterized by an unusual or excessive build-up of body fat, potentially leading to adverse health outcomes. Personalized medicine plays a crucial role in targeting the unique genetic and molecular elements that cause obesity, thus providing customized and efficient treatments for patients. As an illustration, data from December 2024, reported by the Office for Health Improvement and Disparities, a UK-based government department, indicated that from 2022 to 2023, 25.4% of women in early pregnancy were recorded as living with obesity, a figure that saw a slight rise to 26.2% from 2023 to 2024. Consequently, the expanding obese population acts as a significant impetus for the growth of the personalized medicine market.
Which Market Segments Are Examined In The Personalized Medicine Market Study?
The personalized medicine market covered in this report is segmented –
1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness
2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications
3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users
Subsegments:
1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging
2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products
3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring
4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs
Which Trends Are Influencing The Personalized Medicine Market?
Leading companies active in the personalized medicine market are concentrating on developing technological innovations, such as artificial intelligence (AI)-powered platforms, to enhance diagnostic accuracy, individualize treatment, and improve the efficiency of clinical trials. These AI-powered platforms utilize extensive data analysis to generate actionable insights concerning disease progression, patient responses, and therapeutic outcomes. For instance, in April 2023, OM1, a US-based healthcare company that leverages real-world data and AI, patented an AI-powered platform aimed at accelerating personalized medicine. This platform provides tailored healthcare recommendations, supports informed decision-making for healthcare providers, and speeds up clinical trials by efficiently identifying suitable patient candidates. By integrating AI-driven analytics into healthcare operations, this technology advances personalized medicine and strengthens market growth.
Who Are The Primary Competitors In The Personalized Medicine Market?
Major companies operating in the personalized medicine market are Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.
Read the full personalized medicine market report here:
https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report
What Are The Leading Geographic Regions In The Personalized Medicine Market?
North America was the largest region in the personalized medicine market in 2025. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Personalized Medicine Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10272&type=smp
Browse Through More Reports Similar to the Global Personalized Medicine Market 2026, By The Business Research Company
Personalized Medicine Market Report 2026
https://www.thebusinessresearchcompany.com/report/personalized-medicine-global-market-report
Genomics Personalized Health Market Report 2026
https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report
Personalized Nutrition Market Report 2026
https://www.thebusinessresearchcompany.com/report/personalized-nutrition-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model